Search

Author/Creator Sutton, Kenneth C

1. Efficacy, Safety, and Durability of Long-Acting Cabotegravir and Rilpivirine in Adults With Human Immunodeficiency Virus Type 1 Infection: 5-Year Results From the LATTE-2 Study. (25th August 2021)

Authors:
Smith, Graham H R; Henry, W Keith; Podzamczer, Daniel; Masiá, Maria Del Mar; Bettacchi, Christopher J; Arasteh, Keikawus; Jaeger, Hans; Khuong-Josses, Marie-Aude; Montes-Ramírez, Maria Luisa; Stellbrink, Hans-Jürgen; Yazdanpanah, Yazdan; Richmond, Gary J; Sutton, Kenneth C; Zhang, Feifan; McCoig,...
Journal:
Open forum infectious diseases
Issue:
Volume 8:Number 9(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial. Issue 10101 (23rd September 2017)

Authors:
Margolis, David A; Gonzalez-Garcia, Juan; Stellbrink, Hans-Jürgen; Eron, Joseph J; Yazdanpanah, Yazdan; Podzamczer, Daniel; Lutz, Thomas; Angel, Jonathan B; Richmond, Gary J; Clotet, Bonaventura; Gutierrez, Felix; Sloan, Louis; Clair, Marty St; Murray, Miranda; Ford, Susan L; Mrus, Joseph; Patel,...
Journal:
Lancet
Issue:
Volume 390:Issue 10101(2017)
Page Start:
1499
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of Study. (9th February 2022)

Authors:
Sutton, Kenneth C; De Vente, Jerome; Leblanc, Roger; Dejesus, Edwin; Smith, Graham; Mills, Anthony; Baril, Jean-Guy; St. Clair, Marty; Stancil, Britt S; Vandermeulen, Kati; Spreen, William R
Journal:
Open forum infectious diseases
Issue:
Volume 9:Number 4(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗